Legal · Terms of Use
These terms cover what this website is for, what you may do with it, and the limits of what the pharmacy promises about it. They are written for a static information site with one contact form.
They do not govern the supply of a compounded preparation. That is governed by the prescription and by the pharmacy's terms of supply.
This page will be reviewed by legal counsel before launch. Sections marked [TBD] are not yet confirmed.
Last updated
[TBD]
Published by
ReliantRx Pharmacy · [TBD registered name and address]
Governing law
Republic of the Philippines · venue [TBD]
These terms govern your use of the ReliantRx Pharmacy website. By using the site you accept them. If you do not accept them, do not use the site.
They apply to the website only. The supply of a compounded preparation is governed by the prescription, the pharmacy's own terms of supply, and Philippine pharmacy law — not by this page.
Use the site for its purpose: professional and educational information about the pharmacy, and general enquiries through the contact form.
You agree not to submit prescriptions, patient records or health information through the site; not to attempt unauthorised access, scraping, or interference with the site or its forms; not to submit false, misleading or impersonating information; and not to use the contact forms for unsolicited commercial messages.
The pharmacy may block a submission or restrict access where these terms are breached.
Content on this site is professional and educational information about compounding. It is not medical advice, it is not a recommendation for any patient, and it does not replace the judgement of a prescriber or a consultation with one.
Information is published in good faith and reviewed as it changes, but the site is provided “as is” and “as available”. The pharmacy makes no warranty that content is complete, current, or fit for a particular purpose, and no warranty of uninterrupted or error-free availability. Items marked [TBD] are unconfirmed and should not be relied on.
See the Prescription Disclaimer →
The contact form is for general enquiries. It does not create a prescriber account, does not place an order, and does not constitute a prescription.
A submission is not an agreement to supply any preparation. Nothing is prepared without a valid prescription verified with the prescriber.
Personal data submitted through the site is handled as described in the Privacy Notice →
The ReliantRx name, logo, site text, layout, illustrations and code are owned by the pharmacy or its licensors and are protected under Philippine law, including Republic Act No. 8293.
You may read, print and share pages for your own professional or personal reference with attribution intact. You may not reproduce, adapt or republish site content commercially, or use the name or logo, without written permission.
Permission requests: contact the pharmacy →
Where the site links to an external page or embeds a third-party service — for example a map or a spam-protection widget — that content is outside the pharmacy's control and is not endorsed by it.
Third-party services in use on this site: [TBD].
To the fullest extent Philippine law allows, the pharmacy is not liable for indirect, incidental or consequential loss arising from use of this website, from reliance on its content, or from the site being unavailable.
Nothing in these terms limits liability that cannot be limited by law, including liability for death or personal injury caused by negligence, or for fraud.
Any cap on the pharmacy's aggregate liability: [TBD].
These terms are governed by the laws of the Republic of the Philippines.
Exclusive venue for any dispute: [TBD]. Dispute-resolution mechanism, if any, before court action: [TBD].
If any provision of these terms is held unenforceable, the remainder stays in force.
The pharmacy may update these terms as the site changes or as a [TBD] item is confirmed. The last updated date at the top of the page reflects the current version, and continued use of the site after a change means you accept it.
Material changes will be noted on this page rather than announced individually.